These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293 [TBL] [Abstract][Full Text] [Related]
4. Progranulin transcripts with short and long 5' untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression. Capell A; Fellerer K; Haass C J Biol Chem; 2014 Sep; 289(37):25879-89. PubMed ID: 25056957 [TBL] [Abstract][Full Text] [Related]
5. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS. Chitramuthu BP; Kay DG; Bateman A; Bennett HP PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904 [TBL] [Abstract][Full Text] [Related]
6. Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis. Lu L; Zheng L; Si Y; Luo W; Dujardin G; Kwan T; Potochick NR; Thompson SR; Schneider DA; King PH J Biol Chem; 2014 Nov; 289(46):31792-31804. PubMed ID: 25239623 [TBL] [Abstract][Full Text] [Related]
7. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration. Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057 [TBL] [Abstract][Full Text] [Related]
8. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. Fiesel FC; Kahle PJ FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389 [TBL] [Abstract][Full Text] [Related]
9. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002 [TBL] [Abstract][Full Text] [Related]
10. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS. Ishiguro A; Katayama A; Ishihama A FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497 [TBL] [Abstract][Full Text] [Related]
11. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Ito D; Suzuki N Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718 [TBL] [Abstract][Full Text] [Related]
12. Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis. Oyston LJ; Ubiparipovic S; Fitzpatrick L; Hallupp M; Boccanfuso LM; Kwok JB; Dobson-Stone C Sci Rep; 2021 Jul; 11(1):14881. PubMed ID: 34290285 [TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS en route from the nucleus to the cytoplasm. Ederle H; Dormann D FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257 [TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype. Mann DMA; Snowden JS Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023 [TBL] [Abstract][Full Text] [Related]
15. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. Ratti A; Buratti E J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757 [TBL] [Abstract][Full Text] [Related]
16. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723 [TBL] [Abstract][Full Text] [Related]
17. From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. Colombrita C; Onesto E; Buratti E; de la Grange P; Gumina V; Baralle FE; Silani V; Ratti A Biochim Biophys Acta; 2015 Dec; 1849(12):1398-410. PubMed ID: 26514432 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo. Watabe K; Akiyama K; Kawakami E; Ishii T; Endo K; Yanagisawa H; Sango K; Tsukamoto M Neuropathology; 2014 Feb; 34(1):83-98. PubMed ID: 23937386 [TBL] [Abstract][Full Text] [Related]
19. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS). Nihei Y; Ito D; Suzuki N J Biol Chem; 2012 Nov; 287(49):41310-23. PubMed ID: 23048034 [TBL] [Abstract][Full Text] [Related]